The CHARM program consisted of 3 component trials that compared candesartan with placebo in patients with symptomatic heart failure. Two trials randomized patients with LVEF ≤ 40%: CHARM-Alternative, ...

Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...

Early report on modular BioVAT patches in advanced stage C or D disease ...

This study investigated long-term mortality outcomes following transcatheter aortic valve replacement (TAVR) among patients with a left ventricular ejection fraction (LVEF) below 50% and comorbid ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Higher is not necessarily better when it comes to left ventricular ejection fraction (LVEF), according to a retrospective study. Compared with an LVEF of 60-65%, both reduced and elevated LVEFs were ...

Heart failure (HF) substantially impacts the health and financial security of an increasing proportion of the US population. It worsens debility and quality of life and may lead to hospitalization and ...

Credit: Getty Images Worsening renal function may be associated with left ventricular ejection fraction in patients with acute heart failure. Worsening renal function (WRF) may be associated with left ...

After the initial screening history, physical examination, and laboratory assessment, 148 subjects were identified who were potentially eligible and underwent full cardiac evaluation. Twelve subjects ...

Adults who have heart failure with a left ventricular ejection fraction of 40% or more face a high risk of hospitalization for heart failure and cardiovascular death. People who have heart failure ...